Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SKINDLE: R333 Ointment for Discoid Lupus Lesions
NCT01597050Phase 2Completed
- Sponsor
- Rigel Pharmaceuticals, Inc.
- Start
- Aug 2012
- Primary completion
- Sep 2013
- Countries
- 2
01
Overview
A Phase 2 trial of R333 in discoid lupus erythematosus (DLE), systemic lupus erythematosus (SLE), sponsored by Rigel Pharmaceuticals, Inc.. Started Aug 2012; status: completed.
02
Drugs
R333
03
Conditions
discoid lupus erythematosus (DLE)systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on NCT01597050.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01597050.